BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nigro E, Daniele A, Salzillo A, Ragone A, Naviglio S, Sapio L. AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments. Int J Mol Sci 2021;22:5569. [PMID: 34070338 DOI: 10.3390/ijms22115569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yan W, Gao S, Zhang Q, Qi J, Liu G, Teng Y, Wang J, Yan S, Ji B. AdipoRon Inhibits Neuroinflammation Induced by Deep Hypothermic Circulatory Arrest Involving the AMPK/NF-κB Pathway in Rats. Pharmaceutics 2022;14. [PMID: 36432657 DOI: 10.3390/pharmaceutics14112467] [Reference Citation Analysis]
2 Ragone A, Salzillo A, Spina A, Naviglio S, Sapio L. Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines. Front Pharmacol 2022;13:837503. [PMID: 35273510 DOI: 10.3389/fphar.2022.837503] [Reference Citation Analysis]
3 Kelder J, Pang Y, Dong J, Schaftenaar G, Thomas P. Molecular Modeling, Mutational Analysis and Steroid Specificity of the Ligand Binding Pocket of mPRα ( PAQR7): Shared Ligand Binding With AdipoR1 and its Structural Basis. J Steroid Biochem Mol Biol 2022;:106082. [PMID: 35189329 DOI: 10.1016/j.jsbmb.2022.106082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sharma A, Mah M, Ritchie RH, De Blasio MJ. The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes? Pharmacol Ther 2021;:108008. [PMID: 34610378 DOI: 10.1016/j.pharmthera.2021.108008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]